Theravance Biopharma Inc (NASDAQ:TBPH) price closed lower on Friday, May 24, dropping -2.46% below its previous close.
A look at the daily price movement shows that the last close reads $8.55. Taking into account the 52-week price action we note that the stock hit a 52-week high of $11.71 and 52-week low of $8.21. The stock subtracted -8.75% on its value in the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On average, analysts have forecast the company’s revenue for the quarter will hit 15.45M, with the likely lows of 14.7M and highs of 16.27M. The average estimate suggests sales growth for the quarter will likely rise by 12.40% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 72.48M for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow 26.20% above that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TBPH a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that TBPH’s price is at present -9.92% off the SMA20 and -9.33% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 34.45, with weekly volatility standing at 4.67%. The indicator jumps to 4.59% when calculated based on the past 30 days. Theravance Biopharma Inc (NASDAQ:TBPH)’s beta value is holding at 0.24, while the average true range (ATR) indicator is currently reading 0.42.
An analysis of the Theravance Biopharma Inc (NASDAQ:TBPH) stock in terms of its daily trading volume indicates that the 3-month average is 398.02K.
Current records show that the company has 48.09M in outstanding shares. The insiders’ percentage holdings are 9.47% of outstanding shares while the percentage share held by institutions stands at 102.01%. But the -25.80% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
